Стоит ли избегать propylene glycol myristate при беременности? | VeriMom
No authoritative reproductive hazard assessment (no harmonised H360/H361 in Annex VI was confirmed; no SCCS or CIR safety assessment indicating reproductive toxicity). As a fatty ester emollient, no pregnancy-specific toxicity data were found in available regulatory sources. Topical dermal absorption is expected to be low but measurable for such esters, so exposure is scored as low (e=1). Sources consulted: ECHA C&L (notifications), PubChem, CosIng, CIR, PubMed (no relevant reproductive studies found).
ECHA regulatory hazard statements
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- Безопасен ли propylene glycol myristate при беременности?
- No authoritative reproductive hazard assessment (no harmonised H360/H361 in Annex VI was confirmed; no SCCS or CIR safety assessment indicating reproductive toxicity). As a fatty ester emollient, no pregnancy-specific toxicity data were found in available regulatory sources. Topical dermal absorption is expected to be low but measurable for such esters, so exposure is scored as low (e=1). Sources consulted: ECHA C&L (notifications), PubChem, CosIng, CIR, PubMed (no relevant reproductive studies found).
- Безопасен ли propylene glycol myristate при грудном вскармливании?
- No evidence of reproductive or lactation-specific toxicity in authoritative reviews; no known mechanism for transfer into breast milk. Dermal absorption expected low but measurable leading to low maternal systemic exposure (e=1). Sources: same as for pregnancy (ECHA C&L self-notifications, PubChem, CosIng, CIR, PubMed).
- Безопасен ли propylene glycol myristate для кожи малыша?
- No infant-specific toxicity or developmental data identified. Because infant skin has higher permeability and surface-area-to-weight, exposure score is increased by +1 relative to adults (adult e=1 → infant e=2). No evidence supports increased hazard or a reproductive mechanism in infants. Sources: CosIng, PubChem, ECHA C&L, PubMed (no infant-specific studies found).
- Как VeriMom оценивает propylene glycol myristate?
- VeriMom оценивает propylene glycol myristate в 33/100 (высокий риск) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы propylene glycol myristate при беременности?
- См. наш список безопасных альтернатив propylene glycol myristate с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.